Search results
Results from the WOW.Com Content Network
5% in reproductive age women [2] Hyperandrogenism is a medical condition characterized by high levels of androgens. It is more common in women than men. [4] Symptoms of hyperandrogenism may include acne, seborrhea, hair loss on the scalp, increased body or facial hair, and infrequent or absent menstruation.
Hyperestrogenism can be caused by ovarian tumors, [2] genetic conditions such as aromatase excess syndrome (also known as familial hyperestrogenism ), or overconsumption of exogenous sources of estrogen, including medications used in hormone replacement therapy and hormonal contraception. [3] Liver cirrhosis is another cause, though through ...
Specialty. Psychiatry. Hypersexuality is a term used for a presumed mental disorder that causes unwanted or excessive sexual arousal, causing people to engage in or think about sexual activity to a point of distress or impairment. [1] It is controversial whether it should be included as a clinical diagnosis [1] [2] used by mental healthcare ...
It is widely used in the treatment of acne, excessive hair growth, and hyperandrogenism in women, who have much lower testosterone levels than men. [98] [99] Because of its antimineralocorticoid activity, spironolactone has antimineralocorticoid side effects [103] and can cause high potassium levels .
The laws also make exceptions for gender-affirming treatments that are not part of a gender transition, such as medications to stop breast growth in boys and excessive facial hair in girls.
Aromatase excess syndrome (AES or AEXS) is a rarely diagnosed genetic and endocrine syndrome which is characterized by an overexpression of aromatase, the enzyme responsible for the biosynthesis of the estrogen sex hormones from the androgens, in turn resulting in excessive levels of circulating estrogens and, accordingly, symptoms of hyperestrogenism.
This treatment method focuses on reducing the anxiety that is caused by the condition and pushes the patient to develop effective distraction and relaxation techniques. Epidemiology. PGAD is very rare and is believed to affect about 1% of women, and is considered even more rare in men.
t. e. Masculinizing hormone therapy, also known as transmasculine hormone therapy or female-to-male (or FTM) hormone therapy, is a form of hormone therapy and gender affirming therapy which is used to change the secondary sexual characteristics of transgender people from feminine or androgynous to masculine. [1] [2] [3] It is a common type of ...